Online Question-answering and Conventional Consultation With a Dermatologist

This study is not yet open for participant recruitment. (see Contacts and Locations)
Verified October 2013 by University of Zurich
Sponsor:
Information provided by (Responsible Party):
University of Zurich
ClinicalTrials.gov Identifier:
NCT01969422
First received: October 10, 2013
Last updated: October 21, 2013
Last verified: October 2013
  Purpose

Comparison of online question-answering system and conventional consultation for dermatological questions:

  • same diagnosis?
  • same information, which had been collected?
  • same recommendations about treatment?
  • what were the relevant differences of the two?

Condition Intervention Phase
Skin Diseases
Procedure: observation
Phase 4

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Retrospective
Official Title: Online Question-answering and Conventional Consultation With a Dermatologist

Resource links provided by NLM:


Further study details as provided by University of Zurich:

Primary Outcome Measures:
  • Correlation of online and clinical diagnosis by Spearman's Rho [ Time Frame: physical consultation date ] [ Designated as safety issue: No ]

Estimated Enrollment: 100
Study Start Date: November 2013
Estimated Study Completion Date: September 2015
Estimated Primary Completion Date: September 2015 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
observation group
observation
Procedure: observation
intervention is the contact with online question answering serice ad subseudd

Detailed Description:

mainly, ICD codes and dermatological diagnosis codes according to the AAD will be used.

  Eligibility

Ages Eligible for Study:   1 Year and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

persons with a question on skin disease

Criteria

Inclusion criteria:

- a conventional dermatological consultation after a question in the online question-answering system.

Exclusion criteria:

-power of veto after information of patient

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01969422

Contacts
Contact: Guenther Hofbauer, Prof MD hofbauer@usz.ch

Locations
Switzerland
University Hospital Zurich, Department of Dermatology Not yet recruiting
Zurich, ZH, Switzerland, 8091
Sponsors and Collaborators
University of Zurich
Investigators
Principal Investigator: Guenther Hofbauer, Prof MD University Hospital Zurich, Department of Dermatology
  More Information

No publications provided

Responsible Party: University of Zurich
ClinicalTrials.gov Identifier: NCT01969422     History of Changes
Other Study ID Numbers: 2013-0340
Study First Received: October 10, 2013
Last Updated: October 21, 2013
Health Authority: Switzerland: Swissmedic

Additional relevant MeSH terms:
Skin Diseases

ClinicalTrials.gov processed this record on September 18, 2014